Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Clinical trial NCT01950819 · COMPLETED

Trial details

NCT number: NCT01950819
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

End Stage Renal Disease (ESRD)Chronic Kidney Disease (CKD)Hemodialysis Renal Replacement Therapy Renal Transplantation

Start date: 2013-12-03
Primary completion: 2017-02-01
Enrollment: 2037

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.